Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Cash Flow-to-Debt Ratio
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥282.81 Million could theoretically repay 0% of its total liabilities (CN¥11.55 Billion) in one year. See Zhejiang Huahai Pharmaceutical Co Ltd (600521) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Also explore 600521 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year debt coverage analysis for Zhejiang Huahai Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600521 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥1.23 Billion | CN¥12.05 Billion | ▼ -47.2% |
| 2024 | 0.19x | CN¥2.17 Billion | CN¥11.24 Billion | ▼ -9.8% |
| 2023 | 0.21x | CN¥2.22 Billion | CN¥10.35 Billion | ▲ +79.4% |
| 2022 | 0.12x | CN¥1.24 Billion | CN¥10.41 Billion | ▲ +10.6% |
| 2021 | 0.11x | CN¥938.43 Million | CN¥8.69 Billion | ▼ -56.5% |
| 2020 | 0.25x | CN¥1.56 Billion | CN¥6.27 Billion | ▼ -29.9% |
| 2019 | 0.35x | CN¥1.75 Billion | CN¥4.95 Billion | ▲ +3114.7% |
| 2018 | 0.01x | CN¥67.90 Million | CN¥6.16 Billion | ▼ -93.5% |
| 2017 | 0.17x | CN¥546.24 Million | CN¥3.21 Billion | ▼ -15.6% |
| 2016 | 0.20x | CN¥433.10 Million | CN¥2.15 Billion | ▲ +85.3% |
| 2015 | 0.11x | CN¥195.31 Million | CN¥1.80 Billion | ▼ -58.8% |
| 2014 | 0.26x | CN¥328.61 Million | CN¥1.24 Billion | ▼ -22.0% |
| 2013 | 0.34x | CN¥490.29 Million | CN¥1.45 Billion | ▲ +76.2% |
| 2012 | 0.19x | CN¥243.83 Million | CN¥1.27 Billion | ▲ +2.0% |
| 2011 | 0.19x | CN¥197.51 Million | CN¥1.05 Billion | ▼ -53.7% |
| 2010 | 0.41x | CN¥299.47 Million | CN¥735.92 Million | ▼ -33.0% |
| 2009 | 0.61x | CN¥317.44 Million | CN¥522.98 Million | ▲ +198.8% |
| 2008 | 0.20x | CN¥84.20 Million | CN¥414.51 Million | ▼ -57.2% |
| 2007 | 0.47x | CN¥136.52 Million | CN¥287.78 Million | ▲ +36.2% |
| 2006 | 0.35x | CN¥77.54 Million | CN¥222.66 Million | ▲ +12.8% |
| 2005 | 0.31x | CN¥53.30 Million | CN¥172.70 Million | ▼ -79.3% |
| 2004 | 1.49x | CN¥163.73 Million | CN¥110.03 Million | ▲ +180.2% |
| 2003 | 0.53x | CN¥47.41 Million | CN¥89.27 Million | ▲ +18.2% |
| 2002 | 0.45x | CN¥75.34 Million | CN¥167.62 Million | ▲ +81.8% |
| 2001 | 0.25x | CN¥37.51 Million | CN¥151.72 Million | — |